Inventor

CHAKRABORTY TIRTHA

US44 patents

⚠️ This page may combine multiple inventors who share the name “CHAKRABORTY TIRTHA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHAKRABORTY TIRTHA

MODERNA THERAPEUTICS INC

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

Modified polynucleotides for the production of oncology-related proteins and peptides

In vivo production of proteins

Modified polynucleotides encoding apoptosis inducing factor 1

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

Modified polynucleotides for the production of nuclear proteins

Modified polynucleotides for the production of proteins

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

Modified polynucleotides encoding aquaporin-5

In vivo production of proteins

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

Modified polynucleotides for the production of secreted proteins

Modified polynucleotides encoding citeD4

Modified polynucleotides encoding basic helix-loop-helix family member E41

Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1

Modified polynucleotides for treating galactosylceramidase protein deficiency

Modified polynucleotides for treating protein deficiency

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

Modified polynucleotides for the production of nuclear proteins

Modified polynucleotides encoding septin-4

Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator

Modified polynucleotides encoding granulysin

Modified polynucleotides for the production of proteins

Modified polynucleotides for the production of proteins associated with human disease

Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1

MODERNATX INC

Terminally modified RNA

Modified Polynucleotides for the production of biologics and proteins associated with human disease

Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of use

Terminally modified RNA

Modified polynucleotides for the production of biologics and proteins associated with human disease

Modified polynucleotides for the production of secreted proteins

Manufacturing methods for production of RNA transcripts

Methods for therapeutic administration of messenger ribonucleic acid drugs

Methods for therapeutic administration of messenger ribonucleic acid drugs

Terminally modified RNA

Signal-sensor polynucleotides for the alteration of cellular phenotypes

Long-lived polynucleotide molecules

Methods for therapeutic administration of messenger ribonucleic acid drugs

VERTEX PHARMA

Materials and methods for treatment of hemoglobinopathies

Materials and methods for treatment of hemoglobinopathies

CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof

Materials and methods for treatment of hemoglobinopathies

modeRNA Therapeutics

Modified polynucleotides for the production of biologics and proteins associated with human disease

MODERNA TX INC

Terminally Modified RNA